Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$465M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$268M |
| 3 |
Verizon
VZ
|
+$239M |
| 4 |
Microsoft
MSFT
|
+$212M |
| 5 |
Apple
AAPL
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$421M |
| 2 |
Becton Dickinson
BDX
|
+$213M |
| 3 |
Home Depot
HD
|
+$191M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$132M |
| 5 |
Broadcom
AVGO
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.96% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCPC
976
Balchem Corp
BCPC
$5.7B
| $44.7M | 0.01% |
264,911
+3,191
| +1% | +$512K |
|
977
UFP Industries
UFPI
$5.24B
| $44.6M | 0.01% |
484,280
+10,845
| +2% | +$912K |
|
978
B&G Foods
BGS
$286M
| $44.4M | 0.01% |
1,444,603
+57,780
| +4% | +$1.77M |
|
979
Rithm Capital
RITM
$5.64B
| $44.3M | 0.01% |
4,135,716
+125,432
| +3% | +$1.4M |
|
980
Ultragenyx Pharmaceutical
RARE
$2.46B
| $44.2M | 0.01% |
526,183
+12,334
| +2% | +$1M |
|
981
Teladoc Health
TDOC
$1.26B
| $44.2M | 0.01% |
481,716
+10,673
| +2% | +$1.28M |
|
982
Diodes
DIOD
$3.93B
| $44.2M | 0.01% |
402,407
+26,042
| +7% | +$2.64M |
|
|
SWN
983
DELISTED
Southwestern Energy Company
SWN
| $44.1M | 0.01% |
9,472,444
+2,733,354
| +41% | +$13.6M |
|
984
Cohen & Steers
CNS
$4.33B
| $43.9M | 0.01% |
474,582
+30,945
| +7% | +$2.87M |
|
985
UMB Financial
UMBF
$11.2B
| $43.9M | 0.01% |
413,433
+5,035
| +1% | +$519K |
|
986
BWX Technologies
BWXT
$15.4B
| $43.8M | 0.01% |
914,423
+15,506
| +2% | +$811K |
|
987
Bankunited
BKU
$3.43B
| $43.8M | 0.01% |
1,034,664
+55,696
| +6% | +$2.33M |
|
988
Iridium Communications
IRDM
$5.13B
| $43.7M | 0.01% |
1,059,476
+27,656
| +3% | +$1.12M |
|
|
CIT
989
DELISTED
CIT Group Inc.
CIT
| $43.7M | 0.01% |
851,913
+5,634
| +0.7% | +$287K |
|
990
Rogers Corp
ROG
$2.36B
| $43.7M | 0.01% |
160,026
+1,620
| +1% | +$394K |
|
991
Curtiss-Wright
CW
$27.6B
| $43.6M | 0.01% |
314,689
-7,329
| -2% | -$967K |
|
992
Alkermes
ALKS
$8.32B
| $43.6M | 0.01% |
1,873,225
-61,454
| -3% | -$1.62M |
|
993
Clarivate
CLVT
$1.24B
| $43.5M | 0.01% |
1,850,550
+39,114
| +2% | +$906K |
|
994
OGE Energy
OGE
$9.71B
| $43.5M | 0.01% |
1,132,868
+37,011
| +3% | +$1.3M |
|
995
Reinsurance Group of America
RGA
$15.5B
| $43.4M | 0.01% |
396,760
+15,600
| +4% | +$1.73M |
|
996
Neurocrine Biosciences
NBIX
$16.4B
| $43.4M | 0.01% |
509,615
+12,547
| +3% | +$1.15M |
|
997
JetBlue
JBLU
$2.4B
| $43.4M | 0.01% |
3,044,265
+122,125
| +4% | +$1.8M |
|
|
AQUA
998
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $43.2M | 0.01% |
924,349
+35,623
| +4% | +$1.55M |
|
999
ArcBest
ARCB
$3.17B
| $43.2M | 0.01% |
360,499
-17,420
| -5% | -$1.77M |
|
1000
APi Group
APG
$18.1B
| $43.1M | 0.01% |
2,511,173
+186,972
| +8% | +$2.87M |
|
Similar funds
Charles Schwab's Q4 2021 Portfolio in Review
As of Q4 2021, Charles Schwab held 3,647 positions worth $339B, up 11% from $306B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab's Q4 2021 filing shows 148 new, 2,571 increased, 501 reduced and 58 closed positions. Its largest new stake was Kyndryl: 2,951,149 shares worth $53.4M. The largest sale was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, an estimated $421M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2021 buy was Kyndryl: 2,951,149 shares worth $53.4M.
- Charles Schwab added most to State Street SPDR Portfolio Short Term Treasury ETF in Q4 2021, an estimated $465M increase.
- Charles Schwab's biggest Q4 2021 reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, cutting an estimated $421M.
- Charles Schwab fully exited Kansas City Southern in Q4 2021, selling an estimated $113M.
- Charles Schwab's ten largest holdings make up 18% of its $339B portfolio in Q4 2021.
- Charles Schwab opened 148 new positions and closed 58 in Q4 2021.
- Charles Schwab's portfolio value rose 11% quarter-over-quarter to $339B.
Based on Charles Schwab's 13F filing for Q4 2021, filed 11 Feb 2022.